Skip to content

DR. ELS VAN MOER

Active
Private limited companyfounded 2006active for 20 yearsVan Hersbekelei 7, 2100 Antwerpen, BelgiumKBO/BCE: BE 0880.329.834
Summary

DR. ELS VAN MOER has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €885,828 and a net result of €174,173. Equity is growing by about 2.8% per year across the filed financial years. Its solvency ranks better than 79% of 20,397 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€1.0mtotal assets 2025
Equity
€885,828
Profit
€174,173
Turnover not published (micro format)
Financial health
94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 49 days early0 of 2 deeds read
Why 94lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 7.71, cash €219,481Figures for financial year 2025 (filed 12-03-2026)Size: total assets €1.0mShow the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 54% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 86.9% of total assets
Liquidity 76-2
short-term debt 11.7% · cash 21.5%
Profitability 90+3
return on assets 17.1%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,058 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026highest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €80,000 on 30-day terms is acceptable
Liquidity ample (current ratio 7.71, compared with 7.34 in 2024, above the usual 1.5; short-term debt: 11.7% and cash: 21.5% of total assets), and 13.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 57% on liquidity, 45% on profitability and 33% on growth.

The bankruptcy probability was computed on 15-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 7.71, cash €219,481
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 12-03-2026)
NBB · annual accounts
lowers risk · Size: total assets €1.0m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 12-03-2026, 49 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
49 days early
2024
51 days early
2023
22 days early
2022
3 days late
2021
32 days early
2020
38 days early
2019
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 27 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 29 March (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end16-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2019 to 2025net €174,173 ▲18.8%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Among the best 9% on equitysector median €124,140 · 20,400 companies €885,828 View
  • Positive: 7 profitable years in a rowprofit 2025: €174,173 7 years View
  • Total assets 20256 financial years filed €1.0m View

By topic

Financials

Financial year
2025
Total assets
€1.0m
Profit
€174,173
Solvency
86.9%
Total assets▼ 0.8%
Net result
20192025
Go to Financials

Timeline

Events
22
Since
2007
Next accounts
by 30-04-2027
  1. 08-04-2024Annual accounts filed
  2. 03-05-2023Annual accounts filed
  3. 30-09-2022Liquidity more than 5 times
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
29-03-2006
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.